A cDNA encoding a novel LTC4 receptor is isolated. Provision of the LTC4 receptor which is a novel protein, enables binding experiments with the use of LTC4. By screening a compound modifying the activity of the LTC4 receptor on the basis of these binding experiments, it becomes possible to develop drugs targeting the LTC4 receptor.
申请公布号
CA2375605(A1)
申请公布日期
2001.03.22
申请号
CA20002375605
申请日期
2000.09.13
申请人
YAMANOUCHI PHARMACEUTICAL CO., LTD.;HELIX RESEARCH INSTITUTE